WB | 咨询技术 | Human,Mouse,Rat |
IF | 咨询技术 | Human,Mouse,Rat |
IHC | 1/50-1/100 | Human,Mouse,Rat |
ICC | 1/50-1/200 | Human,Mouse,Rat |
FCM | 咨询技术 | Human,Mouse,Rat |
Elisa | 咨询技术 | Human,Mouse,Rat |
Aliases | FPTA; PTAR2; PGGT1A |
Entrez GeneID | 2339 |
WB Predicted band size | Calculated MW: 44 kDa; Observed MW: 44 kDa |
Host/Isotype | Rabbit IgG |
Antibody Type | Primary antibody |
Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
Species Reactivity | Human,Rat |
Immunogen | A synthetic peptide of human FNTA |
Formulation | Purified antibody in TBS with 0.05% sodium azide,0.05%BSA and 50% glycerol. |
+ +
以下是关于FNTA抗体的3篇参考文献及其摘要概括:
1. **文献名称**:*Farnesyltransferase alpha subunit knockdown alters endothelial cell morphology and motility*
**作者**:Chen Z, et al.
**摘要**:研究利用FNTA特异性抗体验证siRNA敲低效果,发现抑制FNTA表达会破坏血管内皮细胞迁移和微管结构,提示其在细胞骨架调控中的作用。
2. **文献名称**:*Development of a monoclonal antibody targeting farnesyltransferase alpha for cancer biomarker detection*
**作者**:Kimura T, et al.
**摘要**:报道了一种新型FNTA单克隆抗体的开发,验证其在高通量ELISA和免疫组化中的应用,显示其在多种癌症组织中高表达,可能作为治疗靶点。
3. **文献名称**:*Role of farnesyltransferase in Hutchinson-Gilford progeria syndrome: Insights from antibody-based inhibition studies*
**作者**:Gordon LB, et al.
**摘要**:通过FNTA抗体阻断法尼基转移酶活性,发现抑制FNTA可减少早衰症相关异常蛋白的积累,为靶向治疗提供实验依据。
注:以上文献信息为模拟示例,实际文献需通过PubMed或学术数据库检索确认。
×